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Abstract
Guanylate-binding proteins (GBPs) belong to the dynamin family of large GTPases and represent the major IFN-c-induced
proteins. Here we systematically investigated the mechanisms regulating the subcellular localization of GBPs. Three GBPs
(GBP-1, GBP-2 and GBP-5) carry a C-terminal CaaX-prenylation signal, which is typical for small GTPases of the Ras family, and
increases the membrane affinity of proteins. In this study, we demonstrated that GBP-1, GBP-2 and GBP-5 are prenylated in
vivo and that prenylation is required for the membrane association of GBP-1, GBP-2 and GBP-5. Using co-
immunoprecipitation, yeast-two-hybrid analysis and fluorescence complementation assays, we showed for the first time
that GBPs are able to homodimerize in vivo and that the membrane association of GBPs is regulated by dimerization
similarly to dynamin. Interestingly, GBPs could also heterodimerize. This resulted in hierarchical positioning effects on the
intracellular localization of the proteins. Specifically, GBP-1 recruited GBP-5 and GBP-2 into its own cellular compartment
and GBP-5 repositioned GBP-2. In addition, GBP-1, GBP-2 and GBP-5 were able to redirect non-prenylated GBPs to their
compartment in a prenylation-dependent manner. Overall, these findings prove in vivo the ability of GBPs to dimerize,
indicate that heterodimerization regulates sub-cellular localization of GBPs and underscore putative membrane-associated
functions of this family of proteins.
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Introduction
Guanine nucleotide binding proteins (G proteins) are involved
in important cellular processes, including signal transduction,
translation, vesicle trafficking and exocytosis [1]. G proteins
function as GDP/GTP-regulated switches with an ‘‘inactive’’
GDP-bound state and an ‘‘active’’ GTP-bound state [2]. The
subcellular trafficking of GTPases coordinates their activity in time
and space and regulates their function. The mechanisms
controlling the localization of the proteins from the Ras family
of small GTPases have been extensively studied. Small GTPases
display a general affinity for localization to cellular membranes,
which depends on structural signals [3]. More specifically,
GTPases are characterized by the presence of a carboxyl-terminal
‘‘CaaX’’ motif for prenylation (where ‘‘C’’ represents cysteine, ‘‘a’’
is an aliphatic amino acid and ‘‘X’’ is any amino acid). Prenylation
is a posttranslational modification leading to the attachment of a
lipid hydrophobic moiety which allows the protein to anchor to
cellular membranes. The process of prenylation involves the
addition of a C15 farnesyl or a C20 geranylgeranyl isoprenoid to
the cysteine residue of the CaaX motif by a farnesyl transferase
(FTase) or geranylgeranyl transferase type I (GGTase-I), respec-
tively [4]. Additional structural signals have been described that
further increase membrane affinity; these signals include the
presence of a cluster of polybasic amino acid residues directly
upstream of the CaaX box (K-Ras 4B) or of one or two
palmitoylation sites (H-Ras, N-Ras and K-Ras 4A) [5,6]. Some
other proteins, such as Arf, undergo N-terminal myristoylation [7].
In contrast to small GTPases, relatively little is known about the
mechanisms mediating the localization of GTPases from the
family of guanylate-binding proteins (GBPs). Human GBPs belong
to the dynamin family of large GTPases [8]. Seven GBPs have
been identified in humans (GBP-1 to -7) [9] and five of them
(GBP-1, GBP-2, GBP-3, GBP-4 and GBP-5) have been shown to
be highly induced by IFN-c in eukaryotic cells [10,11]. GBP-1 is
the best-characterized member of the GBP family and mediates
cellular responses to IFN-c in infection and inflammation,
suggesting that GBP-1 may be an important component of the
innate immune response [12–18].
Structurally, GBPs have a molecular weight of 67–73 kDa,
display a high degree of homology and share highly conserved
GTP-binding or hydrolysis domains [19,20]. Among human
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GBPs, three members (GBP-1, GBP-2 and GBP-5) possess a
‘‘CaaX’’ prenylation motif at their C-terminal end, which suggests
an affinity for cellular membranes. Previous biochemical studies
revealed that GBP-1 and GBP-5 are able to form dimers and even
tetramers in vitro, and that they display an oligomerization-
dependent activation of GTP hydrolysis [21,22]. This feature is
characteristic of the family of large GTPases [23]. In the case of
dynamin, it has been shown that the dimerization upon GTP
binding regulates the membrane association of the protein [24,25].
In the present study we investigated whether prenylation and
dimerization regulate the intracellular localization and the
membrane association of the IFN-c-induced GBPs. Considering
the high homology of GBPs and the fact that GBP-1 to GBP-5 are
co-expressed in the cell in response to IFN-c, we hypothesized that
GBPs might also be able to form heterodimers, which may in turn
influence the localization of the proteins.
Results
Prenylation and GBP localization
Computer-assisted analyses indicated that GBP-1 is modified by
the farnesyltransferase (FTase) and suggested that GBP-2 and
GBP-5 are modified by geranylgeranyltransferase I (GGTase-I). In
addition to its prenylation motif, GBP-1 possesses a region rich in
polybasic amino acids (KMRRRK at positions 582 to 587,
abbreviation pB) directly upstream of the CaaX box, which might
increase the affinity of GBP-1 for cellular membranes [26,27]. No
evidence of myristoylation or C-terminal palmitoylation, which
have been shown to regulate the localization of small GTPases,
was found in GBPs. GBP-1 has been previously shown to be
prenylated in vivo [28]. Here we investigated whether GBP-2 and
GBP-5 are prenylated in vivo. Flag-tagged GBP-2 and GBP-5, and
as controls Flag-GBP-1 and the corresponding CaaX mutants
(Flag-GBP-1DCTIS, Flag-GBP-2DCNIL and Flag-GBP-
5DCVLL), were expressed in HeLa cells. Cells were incubated
with [3H]-MVA, a precursor of farnesyl and geranylgeranyl
pyrophosphates, in presence of Lovastatin, an inhibitor of the
endogenous mevalonate metabolic pathway. Flag-tagged proteins
were then immunoprecipitated, separated by SDS-PAGE and
stained with Coomassie blue solution (Fig. 1A). Flag-GBP-1, Flag-
GBP-2 and Flag-GBP-5 incorporated [3H]-MVA while the
respective CaaX deletion mutants did not, as shown by the
fluorography of the gel (Fig. 1B) and quantitative determination of
the radioactivity by scintillation counting (Fig.1C).
The effects of prenylation on the cellular distribution of GBP-1,
GBP-2 and GBP-5 were further investigated. Membrane associ-
ation of Flag-tagged GBP-1, GBP-2, GBP-5 or the corresponding
mutants lacking the prenylation motif (DCTIS, DCNIL and
DCVLL) was analyzed using cell fractionation and western blot
analysis (Fig. 2A). All three GBPs showed an association with
membranes, whereas their respective CaaX deletion mutants were
either not detectable in the membranous fraction (GBP-1DCTIS
and GBP-2 DCNIL) or were present in significantly reduced
amounts (GBP-5DCVLL). GBP-2 was also detected in the nuclear
fraction, confirming a previous localization study [11]. In contrast,
GBP-3 and GBP-4 were not associated with membranes (Figure
S1A). In agreement with previous localization studies, GBP-3 was
exclusively detected in the cytosolic fraction and GBP-4, both in
the cytosol and the nuclear fractions [11]. These results showed
that presence of the CaaX motif is required for the association of
GBPs with membranes.
The localization of GFP-fused GBP-1, GBP-2 and GBP-5 was
also investigated at the single cell level using confocal fluorescence
microscopy (Fig. 2B). The localization of the various GBPs was
confirmed after transfection of Flag-tagged GBP-1, -2 or -5 and
anti-Flag fluorescence staining, thus excluding an effect of GFP on
localization (Fig. S1B). GBP-1 was observed in the cytoplasm of
cells in a diffuse or a granular pattern, or both [Fig. 2B(a),
arrowhead], confirming our previous results [11]. In the presence
of FTase inhibitor (FTI) [Fig. 2B(b)], but not GGTase-I inhibitor
(GGTI) (Fig. S1C), GBP-1 was found to be evenly distributed
throughout the cytoplasm. In the case of GBP-1, the absence of
Figure 1. Human GBP-2 and GBP-5 are prenylated in vivo. HeLa
cells transfected with the empty vector (control) or HeLa expressing
Flag-GBP-1, -2 or -5, as well as the respective DCaaX mutants, were
treated with 200 mCi of [3H]-MVA for 20 h before harvesting. Proteins
were extracted, immunoprecipitated with an anti-Flag antibody and
separated by 10% SDS-PAGE. (A) Coomassie stained gel. GBPs, GBP
mutants are indicated (arrow), as well as the heavy and light chains of
the anti-Flag antibody (arrowheads). An unspecific co-precipitated
protein is visible (star) (B) Fluorogramm of the gel shown in 1A. The gel
was exposed for 3 weeks. (C) Activity measurements of the
immunoprecipitates (in cpm, counts per minutes; one fifth of the
precipitates was used for quantitative determination).
doi:10.1371/journal.pone.0014246.g001
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prenylation abrogated both membrane association and granular
appearance, suggesting that the protein might be associated with
the membranes of vesicular structures. Accordingly, the term
‘‘vesicle-like’’ will be used in the remainder of the paper to describe
the granular distribution pattern of GBP-1. GBP-2 was distributed
evenly throughout the cytoplasm of the cells [Fig. 2B(d)] and was
also detected in the nucleus [Fig. 2B(d), asterisk]. Treatment with
either GGTI or FTI did not influence the localization pattern of
GBP-2 [Fig. 2B(e) and Fig. S1C]. GBP-5 was concentrated in the
perinuclear region [Fig. 2B(g), arrowheads] and co-localized with
the Golgi marker GM130 [Fig. 2B(g), insert, arrowheads] [29].
Treatment with GGTI [Fig. 2B(h)] but not FTI (Fig. S1C)
inhibited the accumulation of GBP-5 at the Golgi, which
confirmed that the protein is geranylgeranylated. Expression of
mutants of GBP-1, -2 and -5, devoid of the CaaX motif, confirmed
the results obtained with the prenylation inhibitors. GBP-1DCTIS
and GBP-5DCVLL localized evenly throughout the cytoplasm,
whereas GBP-2DCNIL was distributed similarly to the wild-type
protein [Fig. 2B(c, f, i)].
Next, the influence of the different CaaX motifs alone on the
localization was examined. To this end, the CaaX sequences of
GBP-1, GBP-2 and GBP-5 (CTIS, CNIL and CVLL) were fused
to the C-terminus of GFP and the intracellular localization of the
respective proteins was analyzed (Fig. 3A). An additional construct
containing the polybasic domain and the CaaX motif of GBP-1
was analyzed (Fig. 3A, GFP-pB-CTIS). All of the fusion proteins
were present in the Golgi but not the ER, as shown by co-
localization with GM130 (Fig. 3A, solid arrowheads) but not
calnexin (Fig. 3A). GFP-pB-CTIS was observed at the plasma
membrane in addition to the Golgi (Fig. 3A, open arrowheads).
Treatment with the respective prenylation inhibitors abolished the
localization of the fusion proteins at the Golgi (Fig. 3B). In
conclusion, we showed that prenylation is necessary for the
association of GBPs with membranes. However, the prenylation
signals were not sufficient to determine alone the target
compartment of GBP-1 and GBP-2.
Homodimerization and GBP localization
Previous biochemical and structural in vitro studies revealed that
GBP-1 can homodimerize in a GTP-dependent manner, which
strongly stimulates its GTPase activity [30]. Accordingly, we
investigated whether GBP-1, GBP-2 and GBP-5 were able to
Figure 2. The CaaX box of GBP-1, GBP-2 and GBP-5 is necessary for the association of the proteins with membranes. (A) HeLa cells
expressing Flag-GBP-1, -2 or -5, as well as the respective DCaaX mutants, were fractionated into cytosolic, membranous and nuclear fractions which
were analyzed by western blot. GAPDH was used as a marker of the cytosolic fraction, lamin A/C as a marker of the nuclear fraction and cadherin as a
marker for the membrane fraction. (B) HeLa cells were transiently transfected with Flag-GFP-GBP-1, Flag-GFP-GBP-2 and Flag-GFP-GBP-5. Cells were
either left untreated (a, d, g) or treated with FTI (b, inhibition of GBP-1 farnesylation) and GGTI (e and h, inhibition of GBP-2 and GBP-5
geranylgeranylation, respectively). The presence of GBP-2 in the nucleus is indicated by an asterisk (d and f). Alternatively, HeLa cells were transiently
transfected with plasmids expressing GFP-GBP fusion proteins lacking the CaaX box: (c) Flag-GFP-GBP-1DCTIS, (f) Flag-GFP-GBP-2DCNIL and (i) Flag-
GFP-GBP-5DCVLL. The insert in (e) shows a co-localization (yellow, arrowhead) between GFP-GBP-5 in green and the Golgi marker GM130 in red.
Nuclei were counterstained with DAPI and the Golgi apparatus was stained with an anti-GM130 antibody and an anti-mouse-Alexa546 secondary
antibody. Scale bars = 25 mm.
doi:10.1371/journal.pone.0014246.g002
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homodimerize in vivo using a co-immunoprecipitation approach.
Flag-tagged and VSV-tagged GBPs were expressed in HeLa cells
(Fig. 4A, INPUT). Immunoprecipitation of the Flag-tagged
proteins resulted in the co-precipitation of the VSV-tagged
counterparts (Fig. 4A, IP:Flag). Flag-GFP was used as a negative
control and did not precipitate any VSV-GBP (Fig. 4A, right
panel). Results were confirmed by reciprocal co-immunoprecipi-
tation using an anti-VSV antibody (Figure S2A). Homodimeriza-
tion of GBP-1, GBP-2 and GBP-5 was confirmed using a yeast-
two-hybrid assay (Text S1 and Fig. S3A).
Next, the intracellular localization of homodimers of GBP-1,
GBP-2 and GBP-5 was investigated using a bimolecular
fluorescence complementation assay. In this assay, amino-terminal
(Venus1) and carboxyl-terminal (Venus2) sub-fragments of the
YFP mutant ‘‘Venus’’ can reconstitute and generate de novo
fluorescence if fused to interacting proteins [31,32,33]. Venus1
and Venus2 were fused with the N-terminus of the three GBPs.
Lamin C was used as control because it can dimerize but localizes
to the nucleus and therefore should not contact the cytoplasmic
GBPs [34]. In order to verify the specificity of the method,
homodimerization of Venus-GBPs was quantitatively analyzed by
flow cytometry. Significantly increased numbers of fluorescent cells
were observed when Venus1- and Venus2-GBPs were co-
transfected (Fig. 4B, black bars; GBP-1: 38%, GBP-2: 25.8%
and GBP-5: 20.8%) as compared to co-transfection of each
Venus1-GBP with Venus2-lamin (Fig. 4B, gray bars; ,6%). The
intracellular localization of the homodimers of GBP-1, GBP-2 and
GBP-5 was then assessed using confocal microscopy (Fig. 4C). No
signal was observed after co-expression of Venus1-lamin with
VSV-Venus2-GBP-1, -2 or -5 (Fig. S3B). The Venus interaction
signal of GBP-1 was strictly granular indicating that homodimers
of GBP-1 localize at vesicle-like structures (Fig. 4C, left panel). In
addition, the signal partially concentrated at the plasma
membrane. In the case of GBP-2, a strong Venus signal with a
granular appearance was observed in the perinuclear region
(Fig. 4C, right panel) but did not co-localize with the Golgi marker,
GM130, or the ER marker, calnexin (Fig. S4A). The GBP-5
homodimer localized at the Golgi (Fig. 4C, bottom panel). These
results indicated that homodimers of GBP-1, GBP-2 and GBP-5
localize in specific compartments that only partly overlap with the
general distribution of the proteins and suggested that homo-
dimerization does influence the localization of GBPs.
In order to test the influence of prenylation on the localization
of GBP homodimers, cells were treated with FTI or GGTI.
Fluorescence complementation indicated that all three GBPs could
still dimerize in the absence of prenylation. However the
fluorescent signals were evenly distributed throughout the
cytoplasm (Fig. S4B), indicating that isoprenylation is necessary
for membrane affinity of the dimers.
To characterize more precisely the effect of homodimerization
on the localization of GBP-1, we studied the localization of two
mutants known to be constitutively monomeric or dimeric,
respectively (Fig. 4D). We first used the GTPase-defective mutant,
K51A, which displays reduced nucleotide affinity and hydrolytic
Figure 3. The CaaX motifs of GBPs direct GFP to the Golgi but not to the ER. (A) HeLa cells were transfected with Flag-GFP-CTIS, -CNIL, –
CVLL or a construct containing the polybasic domain and the CaaX box of GBP-1 (GFP-pB-CTIS). Cells were stained with an antibody against the Golgi
marker, GM130, and an anti-mouse-AlexaFluor 546 secondary antibody (upper panel) or against the ER marker, calnexin, (lower panel) using an anti-
rabbit-AlexaFluor 546 secondary antibody. Nuclei were counterstained with DAPI. Co-localization with the Golgi marker GM130 is indicated by solid
arrowheads. Localization at the plasma membrane is indicated by open arrowheads. (B) Prenylation inhibitors abrogate the localization of GFP-CTIS,
GFP-CNIL, GFP-CVLL and GFP-pB-CTIS at the Golgi or the plasma membrane. HeLa cells were transiently transfected with Flag-GFP-CTIS, -pB-CTIS, -
CNIL and -CVLL. Cells were treated with 10 mM FTI and 10 mM GGTI, as indicated. Scale bars = 25 mm.
doi:10.1371/journal.pone.0014246.g003
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activity. This mutant lacks nucleotide-dependent oligomerization
and thus is constitutively monomeric [35]. We found that the
GFP-K51A fusion protein localized evenly throughout the
cytoplasm without any granular accumulation (Fig. 4D). In
addition, the K51A mutant was unable to form homodimers in
the Venus fluorescence complementation assay (figure S5). In
parallel, a constitutively dimeric mutant was generated (R227E/
K228E) [36]. Interestingly, the R227E/K228E mutant was
exclusively associated with vesicle-like structures and at the plasma
membrane, where it co-localized with the actin cytoskeleton
(Fig. 4D, open arrowhead, and S4C). These results indicated that
GBP-1 localizes diffusely as a monomer and is associated with
membranous structures as a dimer.
Heterodimerization and GBP localization
Lastly, it was investigated whether GBPs heterodimerized and
whether this process influenced the subcellular localization of
GBPs (Fig. 5). Co-immunoprecipitation with Flag- and VSV-
tagged proteins showed that all three prenylated GBPs interact
strongly with each other (Fig. 5A). Results were confirmed by
reciprocal co-immunoprecipitation using an anti-VSV antibody
(Figure S2B). Fluorescence complementation confirmed at the
single cell level that GBP-1, -2 and -5 can bind to each other
(Fig. 5B). Co-expression of Venus-GBP-1 with Venus-GBP-2 or
Venus-GBP-5 resulted in a granular fluorescence signal identical
to the GBP-1 homodimer localization pattern (Fig. 5B). This
indicated that GBP-1 directs both GBP-2 and GBP-5 to its
intracellular compartment. The GBP-1 mutant K51A was used as
negative control in the Venus fluorescence complementation assay
and was unable to form heterodimers with wild-type GBP-1, GBP-
2 and GBP-5 (figures S6). Co-expression of Venus-GBP-2 and
Venus-GBP-5 resulted in the localization of the heterodimer at the
Trans-Golgi (Fig. 5B and Fig. S7A). Inhibition of GBP-1
farnesylation induced the localization of GBP-1/GBP-2 and
GBP-1/GBP-5 heterodimers to the compartments of homodimer-
ic GBP-2 and GBP-5, respectively (Fig. S7B). Treatment with
GGTI resulted in a diffuse localization pattern for GBP-2/GBP-5
heterodimers (Fig. S7B). These results showed that GBPs
heterodimers need to be prenylated in order to associate with
membranous structures, similarly to the homodimers.
GFP-GBP-2 and GFP-GBP-5 were expressed in HeLa cells in
presence or in absence of IFN-c in order to investigate whether
endogenous GBP-1 may also affect the localization of both
proteins. After treatment with IFN-c, GFP-GBP-2 displayed a
vesicle-like pattern resembling the GBP-1 localization in 50% of
the cells (Figure S8). In the case of GFP-GBP-5 also, treatment
Figure 4. The in vivo homodimerization of GBPs differentially influences their intracellular localization. (A) GBP-1, GBP-2 and GBP-5 are
able to homodimerize in vivo. HeLa cells were co-transfected with Flag-GBPs or Flag-GFP together with VSV-GBPs or empty control vector (CTL) as
indicated. Protein extracts were immunoprecipitated with an anti-Flag affinity gel and subjected to western blot analysis. For each co-transfection,
cell lysates (10 mg, INPUT) and IP eluates (1:4 for Flag-detection and 3:4 for VSV detection) were analyzed. (B) Quantitative evaluation of the bi-
molecular fluorescence complementation assay. Venus1 plasmids encoding various GBPs were co-transfected with matching Venus2-GBP (black bars)
or Venus2-lamin (gray bars) encoding plasmid into HeLa cells. The number of fluorescent cells was determined by FACS analysis after 72 h. (C) Bi-
molecular fluorescence complementation assay. HeLa cells were transfected with the plasmids expressing GBP-1, -2 or -5 fused with Venus1 or VSV-
Venus2, respectively. Nuclei were counterstained with DAPI. (D) HeLa cells were transfected with different mutants of GBP-1 fused to GFP. Flag-GFP-
GBP-1-K51A is defective in nucleotide-dependent oligomerization. Flag-GFP-GBP-1-R227E/K228E is constitutively dimeric and localizes in vesicle-likes
structures (solid arrowhead) or at the plasma membrane (open arrowhead). Nuclei were counterstained with DAPI. Scale bars = 25 mm.
doi:10.1371/journal.pone.0014246.g004
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with IFN-c induced a vesicle-like distribution but in a lower extend
(,20% of the cells) (Figure S8). These results indicated that
endogenously interferon-induced GBP-1 can also redirect GBP-2
and GBP-5 to its vesicle-like compartment.
Finally it was investigated whether the GBPs harbouring a
CaaX box could bind to non-prenylated GBP-3 and -4, and if so,
whether prenylated GBPs could influence the localization of GBP-
3 and GBP-4. When the proteins are expressed singly, GBP-3 has
been shown to localize in the cytoplasm in a diffuse manner
whereas GBP-4 was evenly distributed throughout the nucleus and
cytoplasm [11]. Both GBP-3 and GBP-4 formed heterodimers
with GBP-1, GBP-2 and GBP-5, as shown by immunoprecipita-
tion (Fig. S9A). The heterodimers formed between GBP-3 or GBP-
4 and GBP-1, -2 or -5 always localized in the compartment of the
prenylated GBPs: with GBP-1 in a vesicle-like compartment, with
GBP-2, around the nucleus and with GBP-5, at the Golgi (Fig. 6
and Fig. S9B). These results indicated that GBPs can hetero-
dimerize and influence the localization of each other in a
hierarchical manner, with the prenylated GBPs being dominant
over the non-prenylated GBPs.
Figure 5. The intracellular localization of GBPs is regulated by heterodimerization in a hierarchical manner. (A) HeLa cells were co-
transfected with Flag-GBPs, Flag-GFP and VSV-tagged GBPs or empty control vector (CTL) as indicated. Cell harvesting, Flag-immunoprecipitation and
western blot analyses were performed as described in Fig. 3A. (B) HeLa cells were co-transfected with plasmids expressing Venus1-GBP and VSV-
Venus2-GBP as indicated. Nuclei were counterstained with DAPI. Scale bars = 25 mm.
doi:10.1371/journal.pone.0014246.g005
Figure 6. Prenylated GBPs recruit non-prenylated GBPs to their
subcellular compartments. HeLa cells were co-transfected with
plasmids expressing Venus1-GBP-1, -GBP-2 or -GBP-5 together with
plasmids expressing GBP-3 or GBP-4 fused to VSV-Venus2. Nuclei were
counterstained with DAPI. Scale bars = 25 mm.
doi:10.1371/journal.pone.0014246.g006
Dimerization GBPs Localization
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Discussion
In the present study, we showed for the first time that GBP-2
and GBP-5 are prenylated in vivo and we confirmed that GBP-1 is
prenylated. In addition, we showed that prenylated GBPs are
associated with cellular membranes. Interestingly, we found that
all GBPs investigated here were able to form homodimers. In case
of GBP-1, dimers exclusively displayed a vesicle-like pattern
partially accumulating at the plasma membrane. Dimers of GBP-2
and GBP-5 were also associated with membranous compartments,
however distinct from the GBP-1 compartment, such as the
perinuclear membrane area in case of GBP-2 and the Golgi in case
of GBP-5. Membrane association of the dimers is corroborated by
the fact that stabilization of prenylated GBP-1, GBP-2 and GBP-5
in their transition state (which corresponds to a tetramer for GBP-
1 and GBP-5) by treatment with aluminum fluoride leads to
membrane association at the Golgi [11,37]. In conclusion, our
data indicated that association of GBPs with cellular membranes
requires not only prenylation but also dimerization.
At this point we cannot exclude that the vesicle-like localization
pattern of dimeric GBP-1 might correspond to protein aggregates.
However, several lines of evidence support an association of the
protein with membranous structures. Firstly, the observed vesicle-
like structures were dependent on prenylation while oligomeriza-
tion of GBP-1, observed in vitro at least to the level of tetramers,
occurs independently of prenylation. Secondly, the presence of
GBP-1 in vesicles is well in agreement with the fact that GBP-1 is
secreted, whereas the formation of aggregates would rather
support the retention of the protein in the cytoplasm [38]. Finally,
it has been shown that farnesylated GBP-1 associates with
liposomes in the active state of GTP hydrolysis [39].
We showed that a part of GBP-1 homodimers associates with
the plasma membrane where they co-localize with the actin
cytoskeleton. This finding suggests a role for human GBP-1 in
signal transduction and cytoskeleton organization and is corrob-
orated by the fact that GBP-1 is known to inhibit spreading of
endothelial cells [18]. Recently, murine GBP-2, which is
considered as the functional homolog of GBP-1, has been shown
to bind and inactivate phosphoinositol 3-kinase, resulting in the
inhibition of Rac activity and of cell spreading [40]. In addition,
GBP-1 has been shown to associate with tight junctions under
inflammatory conditions, however exclusively in intestinal epithe-
lial cells [41]. Taken together, these data suggest a potential role of
GBP-1 in vesicle and membrane biology.
The dimeric forms of all three prenylated GBPs were associated
with different membranous compartments (GBP-1, vesicle-like,
cytoplasmic or plasma membrane; GBP-2, perinuclear mem-
branes; GBP-5, Golgi). In contrast, the isolated CaaX motifs of all
GBPs uniformly targeted GFP to the Golgi. Association with
additional targeting factors may be responsible for these different
localizations. The action of chaperones has been evoked to explain
the specific targeting of Ras, Rho, Rab or heterotrimeric a
subunits GTPases to distinct organelles [42,43,44]. In particular,
guanine dissociation inhibitor (GDI) proteins have been shown to
bind and maintain Rho GTPases and Rab GTPases as soluble
cytosolic proteins [42,45,46]. Dissociation from GDI, in the case of
Rab GTPases through the action of GDI displacement factors
(GDF), allows the GTPases to associate with membranes. Such
proteins may also be involved in the intracellular trafficking of
GBPs.
Dimerization functionally connects the regulation of membrane
association with the GTPase cycle of GBPs in living cells. For
example, GBP-1 hydrolyses GTP into GDP and GMP during two
consecutive steps. First, GBP-1 forms dimers upon binding to GTP
and is transiently present as a tetramer during the GDP-bound
transition phase. Then, GDP is cleaved into GMP which results in
dimer dissociation [21,22,47]. Accordingly, the mixed pattern of
localization of wild-type GBP-1 might reflect the dynamic and
transient association with membranes depending on the GTP
hydrolysis cycle. In contrast to GBP-1, GBP-5 forms dimers in the
nucleotide-free state [22]. Upon GTP binding, a larger complex is
formed until GTP cleavage, when the protein complex dissociates
and GBP-5 becomes again dimeric [22]. The constitutive dimeric
state of GBP-5 corroborates the constitutive membrane association
observed in this study. No biochemical data are available
concerning the oligomeric state of GBP-2 during GTP hydrolysis.
Investigating putative co-operative effects between the different
GBPs, we could show that all the GBPs included in this study have
the ability to heterodimerize and that this results in a localization
hierarchy within the GBPs. Specifically, GBP-1 recruited GBP-5
and GBP-2 into its own cellular compartment and GBP-5
repositioned GBP-2. In addition, GBP-1, GBP-2 and GBP-5 were
able to redirect non-prenylated GBPs to their compartment in a
prenylation-dependent manner. The same may apply for murine
GBPs (mGBPs). It has been shown recently that after IFN-c
stimulation, all mGBPs are expressed and show a discrete vesicle-
like structure inside the cytoplasm [48]. However, in the case of
single ectopic expression, mGBP-1 is evenly distributed through-
out the cytoplasm whereas mGBP-2 demonstrates a vesicle-like
localization pattern [49]. Similarly, it has been shown that mouse
IRG proteins, which also belong to the dynamin large GTPases
family, are able to heterodimerize and to mutually regulate their
subcellular localization [50].
Of note, a striking analogy in intracellular trafficking events has
been described for heteromeric G receptor-coupled small
GTPases. The three members of the family, the proteins Ga,
Gb and Gc, can only reach the plasma membrane when they
multimerize and are appropriately prenylated or acylated [51].
More specifically, dimers of Gb and Gc are formed in the
cytoplasm and, upon prenylation of Gc, the dimers reach the
endoplasmic reticulum and the Golgi apparatus where they
trimerize with the Ga subunit. Acylation of Ga at the Golgi then
allows the G protein heterotrimer to be transported to the plasma
membrane likely via the classic secretory pathway [51]. In the
same way, GBPs may form heterodimers in the cytoplasm and
may be prenylated and processed in the endoplasmic reticulum
and the Golgi before they are targeted to their final membranous
compartment.
Overall our data showed that the association of GBPs with
membranes depends on prenylation and is regulated by dimer-
ization. Moreover, GBPs are able to heterodimerize, which results
in a re-localization of the dimers in a hierarchical manner. The
vesicle-like localization pattern characteristic of GBP-1 homo- and
heterodimers suggests a possible role in vesicle formation or
trafficking, while the association with the actin cortex at the
plasma membrane indicates a potential role in signal transduction
or cytoskeleton organization.
Materials and Methods
Plasmids
The plasmids pMCV1.4 (2) and (+) were obtained from
Mologen (Berlin, Germany). A Flag–tag sequence (abbreviation: F)
and a VSV-tag sequence were cloned into the pMCV1.4(2) and
(+) plasmids using EcoRV/EcoRI or NdeI/EcoRI restriction sites,
respectively. The sequences of GFP and the various GBPs were
inserted in-frame into pMCV1.4-Flag using the EcoRI restriction
site (NCBI accession numbers: GBP-1, NM_002053.2; GBP-2,
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NM_004120.3; GBP-3: NM_018284.2; GBP-4: NM_052941.4;
GBP-5, NM_052942.3). Plasmids expressing GFP-GBP fusion
proteins were obtained by inserting the sequences of GBP-1, -2 or
-5 into the pMCV1.4-Flag-GFP vector using SnaBI and SalI
restriction sites. The plasmids, pMCV1.4-Flag-GFP-CTIS, -CNIL
and –CVLL were generated by cloning the respective CaaX box
coding sequence fused to a glycine linker (consisting of 4 glycines)
between PstI and SalI restriction sites. The plasmids, pMCV
1.4-Flag-GFP-GBP-1DCTIS, pMCV1.4-Flag-GFP-GBP-2DCNIL,
pMCV1.4-Flag-GFP-GBP-5DCVLL and pMCV1.4-Flag-GFP-pB-
CTIS were generated by site-directed mutagenesis (QuikChange II
Mutagenesis kit, Stratagene, La Jolla, CA) using the primers GBP-
1DCTIS forward (59- CAGACGAAAATGAGACGACGAAAGG-
CATAAGTCGACGAATTCAAGC-39), GBP-2DCNIL forward
(59-GCAAATCATTGGAGCCAATATAAGTCGACGAATTCA-
AGC-39) and GBP-5DCVLL forward (59-GGACTGTTAATA-
AACGATGATTCCATAAGTCGACG-39) containing a SalI re-
striction site (underlined). The plasmids pCDNA3.1-Venus1 and
pCDNA3.1-Venus2 were a kind gift from Dr. Stephen Michnick
(University of Montreal, Montreal, Canada). The coding sequences
of Venus1 and Venus2 were inserted between the EcoRI and EcoRV
restriction sites of pMCV1.4 (+) and pMCV1.4-VSV, respectively.
The coding sequences of lamin C, GBP-1, GBP-1 K51A, GBP-2,
GBP-3, GBP-4 and GBP-5 were then inserted into pMCV1.4-
Venus1 and pMCV1.4-VSV-Venus2 at the C-terminus of the Venus
sequence using the EcoRV and XhoI restriction sites.
Cell culture and transfections
HeLa cells were purchased from ATCC and cultured in
DMEM supplemented with 10% (v/v) fetal bovine serum (FBS)
from PAA (Pasching, Austria). Transfections were performed using
the calcium phosphate method [52].
Immunofluorescence analysis
For immunofluorescence and bimolecular fluorescence comple-
mentation assay, HeLa cells were seeded in Lab-Tek chamber-
slides (NuncTM, Thermo Fisher Scientific, Bonn, Germany). One
microgram of plasmid was transfected per well. When indicated,
100 U/ml of IFN-c (Roche Applied Science, Mannheim,
Germany), 10 mM of GGTase-I inhibitor (GGTI-2147) or
10 mM of FTase inhibitor (L744,832) (both from CalbiochemTM,
Merck, Darmstadt, Germany) were added to the cells 8 h after
transfection. Twenty-four hours after transfection, cells were fixed
in 10% buffered formalin (Sigma-Aldrich) and permeabilized in
0.1% Triton X100 (Sigma-Aldrich). The following antibodies were
used for immunofluorescence staining: a rabbit anti-Flag-tag
antibody (diluted 1:500) (ABR, Thermo Fisher Scientific), a mouse
monoclonal anti-VSV (diluted 1:5,000) (Sigma-Aldrich, Schnell-
dorf, Germany), a mouse anti-GM130 antibody (clone 35, diluted
1:1,000) (BD Biosciences, San Jose, CA), a rabbit anti-calnexin
antibody (diluted 1:500) (Santa Cruz, Santa Cruz, CA) or a rabbit
anti-actin antibody (diluted 1:100) (Sigma-Aldrich). Antibodies
were incubated overnight at 4uC in 16TBS with 5% normal goat
serum (Dianova, Hamburg, Germany). After washing, cells were
incubated for 1 h at room temperature with the following
secondary antibodies (diluted 1:500): AlexaFluor 546-conjugated
goat anti-rabbit IgG, AlexaFluor 546-conjugated goat anti-mouse
IgG or AlexaFluor 488-conjugated goat anti-rabbit IgG (Invitro-
gen/Molecular Probes, Darmstadt, Germany). Nuclei were
counterstained with DAPI (1:5,000 in water, Invitrogen/Molec-
ular probes) for 10 min at room temperature. Coverslips were
mounted in fluorescence mounting medium (Dako, Hamburg,
Germany). Fluorescence was visualized using the confocal
microscope, TCS SP5 (Leica Microsystems, Wetzlar, Germany)
using a 636magnification. Pictures were obtained using the LAS
AF software (Leica Microsystems) and the AdobeH PhotoshopH
CS2 software. All images presented are single sections in the z-
plane (airy unit = 1) and are representative of at least 80% of the
transfected cells.
Subcellular fractionation
HeLa cells were seeded in 10-cm dishes and transfected after
24 h with 10 mg of the plasmids, pMCV1.4-Flag-GBP-1, -2, -3, -4
or -5 and pMCV1.4-Flag-GBP-1, -2 or -5DCaaX using the
calcium phosphate method. Twenty-four hours after transfection,
2.56106 cells were harvested and cytoplasmic, membranous or
nuclear fractions were purified using the Qproteome fractionation
kit (Qiagen, Hilden, Germany) according to the manufacturer’s
recommendations.
Immunoprecipitation (IP)
HeLa cells were seeded in culture dishes (NuncTM) and
transfected 24 h later with 10 to 15 mg of DNA as described
above. Cells were harvested 48 h after transfection with a sterile
cell scraper (Nunc) in 1.5 ml of ice-cold IP-lysis buffer (20 mM
Tris-HCl pH 7.5, 150 mM NaCl, 5 mM MgCl2, 1% Igepal and
EDTA-free inhibitor mix: Roche Applied Science). For immuno-
precipitation, 750 mg of protein were incubated with 10 ml of anti-
Flag affinity gel M2 (Sigma-Aldrich) or 5 ml of rabbit anti-VSV
antibody bound to 50 ml of protein A-agarose beads (both Sigma-
Aldrich) overnight at 4uC. Samples were washed with IP-wash
buffer (20 mM Tris-HCl pH 7.5, 150 mM NaCl, 5 mM MgCl2,
0.1% Igepal). Immunoprecipitated proteins were eluted from the
beads by addition of 30 ml of Laemmli buffer [53] and boiled for
10 min. The protein concentration of IP-lysates was determined
using the DC assay (Bio-Rad Laboratories, Munich, Germany).
IP-lysates (10 mg) were resuspended using 26Laemmli buffer and
subsequently subjected to western blot analysis.
Western blot analysis
Ten micrograms of IP-lysates, 8 to 25 ml of IP-eluates or 15 ml
of fractionated samples were separated by electrophoresis on 10%
SDS-PAGE gels and analyzed by western blot as described
previously [16]. The following primary antibodies were used:
mouse monoclonal anti-Flag M2 (1:10,000), mouse monoclonal
anti-VSV-G (1:40,000), rabbit polyclonal anti-Flag (1:400), rabbit
polyclonal anti-VSV-G (1:1,000) (each from Sigma-Aldrich),
mouse anti-GAPDH (1:60,000, Chemicon), goat anti-lamin A/C
(1:1,000, Santa Cruz) and mouse anti-pan-cadherin (1:2,000,
Abcam). A donkey anti-rabbit IgG antibody coupled to horserad-
ish peroxidase (HRP) (GE Healthcare, Munich, Germany), a
donkey anti-goat-HRP (GE Healthcare) and a sheep anti-mouse-
HRP antibody (Dako) were used as the secondary antibodies at the
dilution of 1:5,000. Protein detection was performed using the
enhanced chemiluminescence western blot detection system (ECL,
GE Heathcare) and Rx-films (Fuji, Tokyo, Japan).
Radiolabelling with [3H]-mevalonolactone ([3H]-MVA)
HeLa cells were seeded in 6-wells plates and transfected after
24 h with 5 mg of the plasmids, pMCV1.4-Flag-GBP-1, -2 or -5
and pMCV1.4-Flag-GBP-1, -2 or -5DCaaX. Cells were incubated
for 6 h and then rinsed two times with 16 PBS. Fresh medium
(DMEM+10%FCS) supplemented with 30 mM of Lovastatin
(Sigma-Aldrich) was added. After 3 h, medium was renewed and
200 mCi of [3H]-MVA (Biotrend Chemikalien, Cologne, Ger-
many) was added per well. Cells were incubated for further 20 h.
Cells were lysed and proteins were immunoprecipitated using an
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anti-Flag monoclonal antibody (M2, Sigma-Aldrich) as described
above. One fifth of the immunoprecipitatted was used for
quantitative determination of the radioactivity in 5 ml of Ultima
Gold (Perkin-Elmer, Rotgau, Germany) with a liquid scintillator
analyzer (Perkin-Elmer). The remaining 4/5 of the immunopre-
cipitates was separated by electrophoresis on a 10% SDS-PAGE
gel. The gel was stained for 3 h with Coomassie blue staining
solution (0,025% Coomassie brilliant blue R250, 40% methanol
and 7% acetic acid) and destained for 1 h with 40% methanol and
7% acetic acid. The gel was then equilibrated for 30 min in 4%
glycerol (Sigma-Aldrich), incubated for 30 min in AmplifyH
solution (GE Healthcare), dried overnight using a drying frame
and a cellulose sheet (Invitrogen), and exposed for 3 weeks with a
pre-flashed autoradiography film (GE Healthcare) at 270uC.
FACS analysis
In order to analyze homomeric interactions by flow cytometry,
1 mg (GBP1 and 22) or 2 mg (GBP5) of Venus1 and Venus2
constructs were co-transfected into HeLa cells in 6-well plates as
described above. Cells were detached after 72 h by standard
trypsin/EDTA treatment, collected by centrifugation at 5006g
(4uC, 5 min), washed twice in PBS supplemented with 5% FCS
(4uC), and resuspended in PBS plus 5% FCS (4uC) for subsequent
fluorescent cell enumeration using the FL1 channel (530/30 nm
filter) of a FACSCalibur cytometer (Becton Dickinson, Franklin
Lakes, NJ, USA).
In silico analyses
The analysis of potential prenylation sites was performed using
the prenylation prediction suite PrePS [54]. The search for
palmitoylation or myristoylation signals was performed with the
NMT [55] and the CSS-Palm [56] online applications.
Supporting Information
Text S1
Found at: doi:10.1371/journal.pone.0014246.s001 (0.02 MB
DOC)
Figure S1 Controls for the subcellular localization of GBPs. (A)
Subcellular distribution of GBP-3 and GBP-4. HeLa cells
expressing Flag-GBP-3 or -4 were fractionated into cytosolic,
membranous and nuclear fractions which were analyzed by
western blot. GAPDH was used as a marker of the cytosolic
fraction, lamin A/C as a marker of the nuclear fraction and
cadherin as a marker for the membrane fraction. (B) Localization
of Flag-GBP-1, Flag-GBP-2 and Flag-GBP-5. HeLa cells were
transiently transfected with plasmids expressing Flag-GBP-1, Flag-
GBP-2 and Flag-GBP-5. Cells were stained with an anti-Flag
antibody and an anti-rabbit-AlexaFluor 546 secondary antibody,
and nuclei were counterstained with DAPI. The presence of GBP-
2 in the nucleus is indicated by an asterisk. (C) Controls for
prenylation inhibition. HeLa cells were transiently transfected with
Flag-GFP-GBP-1, Flag-GFP-GBP-2 and Flag-GFP-GBP-5. Cells
were treated with 10 mM FTI and 10 mM GGTI, as indicated.
Nuclei were counterstained with DAPI. Scale bars = 25 mm.
Found at: doi:10.1371/journal.pone.0014246.s002 (5.42 MB TIF)
Figure S2 Reciprocal co-immunoprecipitations. HeLa cells were
co-transfected with Flag-GBPs or Flag-GFP together with VSV-
GBPs or empty control vector (CTL) as indicated. Protein extracts
were immunoprecipitated with an anti-VSV antibody bound to
protein A-agarose and subjected to western blot analysis. For each
co-transfection, cell lysates (10 mg, INPUT) and IP eluates (1:2 for
VSV detection and 1:2 for Flag detection) were analyzed.
Found at: doi:10.1371/journal.pone.0014246.s003 (3.67 MB TIF)
Figure S3 In vivo homodimerization of GBPs.(A) Yeast two
hybrid analysis of homophilic GBP interactions. Two haploid
yeast strains expressing test proteins fused to the DNA-binding
(DA) or activation domain (AD) of the transcription factor Gal4,
were mated to diploid yeast cells and streaked out on selection
plates lacking tryptophan and leucine (diploid growth control) or
on plates additionally lacking histidine and adenine (interaction
test plates). Interactions between test proteins enable yeast growth
on interaction test plates. Test proteins were Gal4 DA-GBP1 (G1),
-GBP2 (G2), -GBP3 (G3), -GBP4 (G4), -GBP5 (G5), and Gal4-AD
(Ctrl). (B) Controls for bi-molecular fluorescence complementation
assay. HeLa cells were co-transfected with plasmids expressing
Venus1-lamin and VSV-Venus2-lamin, -GBP-1, -GBP-2 or -GBP-
5. VSV-Venus2 fusion proteins were stained with an anti-VSV
antibody and an anti-mouse-AlexaFluor 546 secondary antibody,
and nuclei were counterstained with DAPI. The positive control
(Venus1-lamin 6 Venus2-lamin) confirmed that lamin C can
dimerize and forms nucleoplasmic foci after overexpression (62).
The negative controls showed that lamin can not bind to GBPs.
Scale bars = 25 mm.
Found at: doi:10.1371/journal.pone.0014246.s004 (9.05 MB TIF)
Figure S4 Prenylation-dependent localization of GBP homo-
dimers.(A) Dimers of GBP-2 do not co-localize with the Golgi or
the ER. HeLa cells were co-transfected with plasmids expressing
Venus-1-GBP-2 and VSV-Venus2-GBP-2. Cells were stained with
an anti-GM130 antibody and an anti-mouse-AlexaFluor 546
secondary antibody (left) or an anti-calnexin antibody and an anti-
rabbit-AlexaFluor 546 secondary antibody (right). Nuclei were
counterstained with DAPI. (B) Homodimerization of GBP-1,
GBP-2 and GBP-5 is prenylation-dependent. HeLa cells were
pairwise co-transfected with plasmids expressing Venus-1-GBP-1,
-GBP-2 or -GBP-5 together with VSV-Venus2-GBP-1, -GBP-2 or
-GBP-5, respectively. Cells were treated with 10 mM GGTI or
10 mM FTI as indicated. (C) GBP-1 R227E/K228E colocalizes
with the actin cytoskeleton. HeLa cells were transfected with Flag-
GFP-GBP-1-R227E/K228E. Cells were stained with an anti-actin
antibody and an anti-rabbit-AlexaFluor 546 secondary antibody,
and nuclei were counterstained with DAPI. Co-localization is
indicated by solid arrowheads. Scale bars = 25 mm.
Found at: doi:10.1371/journal.pone.0014246.s005 (7.76 MB TIF)
Figure S5 The GBP-1 mutant K51A is unable to form homo- or
heterodimers. HeLa cells were co-transfected with plasmids
expressing Venus1-GBP-1 K51A and VSV-Venus2-GBP-1
K51A, -GBP-1, -GBP-2 or -GBP-5. VSV-Venus2 fusion proteins
were stained with an anti-VSV antibody and an anti-mouse-
AlexaFluor 546 secondary antibody, and nuclei were counter-
stained with DAPI. Scale bars = 25 Aˆmm.
Found at: doi:10.1371/journal.pone.0014246.s006 (9.66 MB TIF)
Figure S6 Reciprocal fluorescence complementation assay.
HeLa cells were co-transfected with plasmids expressing Venus
1-GBP-1, -GBP-2 or -GBP-5 and VSV-Venus2-GBP-1 K51A.
VSV-Venus2 fusion proteins were stained with an anti-VSV
antibody and an anti-mouse-AlexaFluor 546 secondary antibody,
and nuclei were counterstained with DAPI. Scale bars = 25 mm.
Found at: doi:10.1371/journal.pone.0014246.s007 (8.71 MB TIF)
Figure S7 Prenylation-dependent localization of GBP hetero-
dimers.(A) Heterodimers of GBP-2 and GBP-5 localize at the
Golgi. HeLa cells were co-transfected with plasmids expressing
Venus1-GBP-2 and VSV-Venus2-GBP-5. Cells were stained with
an anti-GM130 antibody and an anti-mouse-AlexaFluor 546
secondary antibody, and nuclei were counterstained with DAPI.
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(B) Prenylation is necessary for membrane association of
heterodimers of GBPs. HeLa cells were co-transfected with the
expression plasmids of Venus1-GBP-2 or -5 and VSV-Venus2-
GBP-1. The reciprocal experiments were performed with Venus-
1-GBP-2 and Venus1-GBP-5. VSV-Venus2 fusion proteins were
stained with an anti-VSV antibody and an anti-mouse-AlexaFluor
546 secondary antibody, and nuclei were counterstained with
DAPI. Cells were treated with 10 mM GGTI or 10 mM FTI when
indicated. Scale bars = 25 mm.
Found at: doi:10.1371/journal.pone.0014246.s008 (5.06 MB TIF)
Figure S8 Redistribution of ectopically expressed GBPs in
presence of IFN-c. HeLa cells were transiently transfected with
Flag-GFP-GBP-1, Flag-GFP-GBP-2 and Flag-GFP-GBP-5. Cells
were treated with 100 U/ml of IFN-c as indicated. Nuclei were
counterstained with DAPI. Scale bars = 25 mm.
Found at: doi:10.1371/journal.pone.0014246.s009 (3.95 MB TIF)
Figure S9 Homo- and heterodimerization of GBP-3 and GBP-4.
(A) GBP-3 and GBP-4 are able to homodimerize and to
heterodimerize. HeLa cells were co-transfected with Flag-GBPs
together with VSV-GBPs, as indicated. Protein extracts were
immunoprecipitated with an anti-Flag affinity gel and subjected to
western blot analysis. For each co-transfection, cell lysates (10 mg,
INPUT) and IP eluates (1:4 for Flag-detection and 3:4 for VSV
detection) were analyzed. (B) GBP-3 and GBP-4 do not dimerize
with lamin C. HeLa cells were co-transfected with plasmids
expressing Venus1-lamin and VSV-Venus2-GBP-3 or -GBP-4.
Nuclei were counterstained with DAPI. Scale bars = 25 mm.
Found at: doi:10.1371/journal.pone.0014246.s010 (3.66 MB TIF)
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